Optometrists in Owings Mills, MD Accepting Medicare
23 Optometrists found. Showing 21 - 23
 Dr. Stanley Huber, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 Crossroads Drive, Suite 104, Owings Mills, MD 21117 Phone: 410-654-5700 Fax: 410-654-5399 |
 Accueyes, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10989 Red Run Blvd, Suite 208, Owings Mills, MD 21117 Phone: 410-654-8602 Fax: 410-654-8709 |
 Leah Ostrow, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10369 Reisterstown Rd, Owings Mills, MD 21117 Phone: 443-394-8679 Fax: 443-394-8229 |
News Archive
Stem cell innovation at risk
Despite great hopes for stem cell therapy, major structural and cultural changes within the NHS are needed if it is to succeed in the UK. Currently the chances of getting effective treatments into routine use in the short-term are small and the industry is at serious risk of 'market failure'.
UCSF surgeons formulate operation-triage plan for handling COVID-19 outbreak
Within a month of the University of California San Francisco Health treating its first patient with coronavirus disease 2019 (COVID-19) on Feb. 3, UCSF surgeons began formulating a plan to respond to the pandemic and help manage the health care system's available resources.
Moderate and severe exacerbations associated with decline in physical activity of COPD patients
A study led by researchers from the Barcelona Institute for Global Health, a center supported by the "la Caixa" Banking Foundation, has shown that both moderate and severe exacerbations in COPD patients are associated with a decline in their physical activity level.
Out-of-hours doctors reluctant to do home visits, say patients
Patients feel that doctors providing out-of-hours services in primary care are reluctant to do home visits, shows a small study of patients' experiences in Quality and Safety in Health Care.
Access partners to exploit CobaCyte and CobOral technology for targeted RNAi therapeutic delivery
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
› Verified 8 days ago
- 1
- 2(current)
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Podiatrists
Chiropractors
Audiologists